Frederick L Baehner
Inventor
Stats
- 1 US patents issued
- 10 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 10 US Applications Filed
- 50 Total Citation Count
- Aug 23, 2023 Most Recent Filing
- Sep 4, 2009 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| GENOMIC HEALTH, INC. | 1
3 1 1 | 2009
2011 2015 2016 |
| AVENTISUB II INC. | 1
| 2009
|
Inventor Addresses
| Address | Duration |
|---|---|
| San Francisco, CA, US | Jun 17, 10 - Mar 21, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| C12Q: | MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS | 8 |
| G01N: | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES | 4 |
| G06F: | ELECTRIC DIGITAL DATA PROCESSING | 2 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0096,451 | 2024 | Method to Use Gene Expression to Determine Likelihood of Clinical Outcome of Renal Cancer | 0 |
| 11776664 | 2023 | Method to use gene expression to determine likelihood of clinical outcome of renal cancer | 0 |
| 2022/0396,842 | 2022 | METHOD FOR USING GENE EXPRESSION TO DETERMINE PROGNOSIS OF PROSTATE CANCER | 0 |
| 2022/0051,755 | 2022 | Method to Use Gene Expression to Determine Likelihood of Clinical Outcome of Renal Cancer | 0 |
| 2021/0166,790 | 2021 | Method to Use Gene Expression to Determine Likelihood of Clinical Outcome of Renal Cancer | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.